HLA-DQ6-mediated protection in IDDM

Human Immunology

Volumn 61, Issue 2, 2000, Pages 148-153

  Sanjeevi, Carani B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Genetic susceptibility; HLA DQ; IDDM; Molecular modeling

Indexed keywords

HLA DQ ANTIGEN;

ALLELE; CONFERENCE PAPER; CRYSTAL STRUCTURE; DISEASE ASSOCIATION; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

AGE FACTORS; ALLELES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; SEX FACTORS;

EID: 0033984784     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00146-9     Document Type: Conference Paper

References (34)

1. Thorsby E., Ronningen K.S. Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann Med. 24:(6):1992;523.
2. Sanjeevi C.B., Lybrand T., DeWeese C., Landin-Olsson M., Kockum I., Dahlqvist G., Sundkvist G., Stenger D., Lernmark Å. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes. 44:1995;125.
3. Sanjeevi C.B., Kockum I., Lernmark Å. The role of major histocompatibility complex in insulin-dependent diabetes. Curr Opin Endocrinol Diabetes. 2:1995;3.
4. Graham J., Kockum I., Sanjeevi C.B., Landin-Olsson M., Nyström L., Sundkvist G., Arnqvist H., Blohme G., Lithner F., Littorin B., Schersten B., Wibell L., Östman J., Lernmark Å., Breslow N., Dahlquist G. Negative association between IDDM and HLA DQB1*0602-DQA1*0102 is attenuated with age-at-onset. Eur J Immunogenet. 26:1999;117.
5. Sanjeevi C.B., DeWeese C., Landin-Olsson M., Kockum I., Dahlquist G., Lernmark Å., Lybrand T. Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus. Tissue Antigens. 50:1997;61.
6. Sanjeevi C.B., Landin-Olsson M., Kockum I., Dahlqvist G., Lernmark Å. Effects of the second haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens. 45:1995;148.
7. Bodmer J., Marsh S., Albert E., Bodmer W.F., Bontrop R.E., Charron D., Dupont B., Erlich H.A., Fauchet R., Mach B., Mayr W.R., Parham P., Sasazuki T., Schreuder G.M., Strominger J.L., Svejgaard A., Terasaki P.I. Nomenclature for factors of the HLA system, 1996. Tissue Antigens. 49:1997;297.
8. Sanjeevi C.B., Olerup O. Restriction fragment length polymorphism analysis of HLA-DRB, DQA and DQB genes in South Indians and Swedish Caucasians. Transplant Proc. 24:1992;1687.
9. Mehra N.K., Verduijn W., Taneja V., Drabbels J., Singh S.P., Giphart M.J. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population. Hum Immunol. 32:(4):1991;246.
10. Mehra N.K., Bouwens A.G., Naipal A., Rajalingam R., Grubic Z., Taneja V., Tilanus M.G., Giphart M.J. Asian Indian HLA-DR2-, DR4-, and DR52-related DR-DQ genotypes analyzed by polymerase chain reaction based nonradioactive oligonucleotide typing. Unique haplotypes and a novel DR4 subtype. Hum Immunol. 39:(3):1994;202.
11. Serjeantson S., Ranford P., Kirk R., Kohonen-corish M., Mohan V., Ramachandran A., Snehalatha C., Viswanathan M. HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India. Dis Markers. 5:1987;101.
12. Rønningen K.S., Spurkland A., Tait B.D., Drummond B., Lopez-Larrea C., Baranda F.S., Thorsby E. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese. 1991;Oxford University Press, Oxford.
13. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 322:1990;1836.
14. Reijonen H., Ilonen J., Åkerblom H., Knip M., Dosch H.-M. Multilocus analysis of HLA class II genes in DR2 positive IDDM haplotypes in Finland. Tissue Antigens. 43:1994;1.
15. Zeliszewski D., Tiercy J.-M., Boitard C., Gu X.-F., Loche M., Krishnamoorthy R., Simonney N., Elion J., Bach J.-F., Mach B., Sterkers G. Extensive study of DRB, DQA and DQB gene polymorphism in 23 DR2-positive insulin-dependent diabetes mellitus patients. Hum Immunol. 33:1992;140.
16. Sanjeevi C.B., Lybrand T.P., Landin-Olsson M., Kockum I., Dahlquist G., Hagopian W.A., Palmer J.P., Lernmark Å. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2 positive patients with insulin-dependent diabetes mellitus. Tissue Antigens. 44:1994;110.
17. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Stominger J.L., Wiley D.C. Three-dimentional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:1993;33.
18. Kockum I., Wassmuth R., Holmberg E., Michelsen B., Lernmark Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in Type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet. 53:1993;150.
19. Stern L.J., Brown J.H., Jardetsky T.S., Gorga J.C., Urban R.G., Stominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215.
20. Sanjeevi CB: Molecular mechanism of HLA class II association with insulin-dependent diabetes mellitus. Thesis submitted to Karolinska Institute, Stockholm, Sweden. 49-55, 1994.
21. Caillat-Zucman S., Garchon H.J., Timsit J., Assan R., Boitard C., Dkilali-Saiah I., Bougueres P., Bach J.F. Age dependent HLA genetic heterogeniety of Type 1 insulin-dependent diabetes mellitus. J Clin Invest. 90:(6):1992;2242.
22. Nystrom L., Dahlquist G., Ostman J., Wall S., Arnqvist H., Blohme G., Lithner F., Littorin B., Schersten B., Wibell L. Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age indications of climatological determinants for age at onset . Int J Epidemiol. 21:1992;352.
23. Blom L., Persson L.A., Dahlquist G. Growth velocity and development of insulin-dependent diabetes mellitus. Diabetologia. 35:1992;528.
24. Hjelmstrom P., Giscombe R., Lefvert A.K., Pirskanen R., Kockum I., Landin O.M., Sanjeevi C.B. Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis. Autoimmunity. 22:(1):1995;59.
25. Hjelmstrom P., DeWeese S.C., Penzotti J.E., Lybrand T.P., Sanjeevi C.B. Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling. J Neuroimmunol. 85:(1):1998;102.
26. Hoover M.L., Marta R.T. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Scand J Immunol. 45:(2):1997;193.
27. Pugliese A., Gianani R., Moromisato R., Awdeh Z.L., Alper C.A., Erlich H.A., Jackson R.A., Eisenbarth G.S. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes. 44:(6):1995;608.
28. Gianani R., Verge C.F., Moromisato G.R., Yu L., Zhang Y.J., Pugliese A., Eisenbarth G.S. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele. J Autoimmun. 9:(3):1996;423.
29. Honeyman M.C., Harrison L.C., Drummond B., Colman P.G., Tait B.D. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med. 1:(5):1995;576.
30. Ettinger R.A., Kwok W.W. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J Immunol. 160:(5):1998;2365.
31. Ettinger R.A., Liu A.W., Nepom G.T., Kwok W.W. Exceptional stability of the HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus. J Immunol. 161:(11):1998;6439.
32. Nepom G.T. A unified hypothesis for the complex genetics of HLA associations. Diabetes. 39:1990;1153.
33. Nepom G.T., Kwok W.W. Molecular basis for HLA-DQ associations with IDDM. Diabetes. 47:(8):1998;1177.
34. Schmidt D., Verdaguer J., Averill N., Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med. 186:(7):1997;1059-1075.